MACULAR DEGENERATION || Public Health Genomics Knowledge Base (v1.2)

https://phgkb.cdc.gov/GAPPKB/phgHome.do;jsessionid=116833B331E9C041466E369B724A9D3B




Last Posted: Apr 06, 2017

---

• The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment.  
  Geerlings Maartje J et al. Molecular immunology 2017 Apr 8465-76
• Genetic pleiotropy between age-related macular degeneration and 16 complex diseases and traits  
  F Grassman et al, Genome Medicine, March 2017
• Facts About Age-Related Macular Degeneration  
  NIH, National Eye Institute
• A Value-Based Medicine cost-utility analysis of genetic testing for neovascular macular degeneration.  
  Brown Gary C et al. International journal of retina and vitreous 2015 119
• Genetic screening for neovascular AMD: cost effective…not so quick.  
  Reichel Elias et al. International journal of retina and vitreous 2015 124
• AMD and the alternative complement pathway: genetics and functional implications  
  PL Tan et al, BMC Human Genomics, July 2016
• Alternative RNA splicing: contribution to pain and potential therapeutic strategy.  
  Donaldson Lucy F et al. Drug discovery today 2016 Jun
• Risk factors and biomarkers of age-related macular degeneration.  
  Lambert Nathan G et al. Progress in retinal and eye research 2016 May
• The Application of Genetic Risk Scores in Age-Related Macular Degeneration: A Review.  
  Cooke Bailey Jessica N et al. Journal of clinical medicine 2016 5(3)
• Learn About Age-Related Macular Degeneration
  Her father lost vision in one eye
• Genetic epidemiology with a capital E, ten years after.  
  Khoury Muin J et al. Genetic epidemiology 2011 Dec 35(8) 845-52
• Current landscape of direct-to-consumer genetic testing and its role in ophthalmology: a review.  
  Sanfilippo Paul G et al. Clinical & experimental ophthalmology 2015 Aug 43(6) 578-90
• Age-related macular degeneration: Complement in action.  
  van Lookeren Campagne Menno et al. Immunobiology 2015 Dec
• Who is at risk for age-related macular degeneration  
  National Eye Institute
• Dietary profile of patients with Stargardt's disease and Retinitis Pigmentosa: is there a role for a nutritional approach?  
  Sofi Francesco et al. BMC ophthalmology 2016 (1) 13
• Let there be light: gene and cell therapy for blindness.  
  Dalkara Deniz et al. Human gene therapy 2016 Jan

more